Crestwood Advisors Group LLC Pfizer Inc Transaction History

Crestwood Advisors Group LLC

  • $5.07 Billion
  • Q3 2024

A detailed history of Crestwood Advisors Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 134,515 shares of PFE stock, worth $3.69 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
134,515
Previous 134,204 0.23%
Holding current value
$3.69 Million
Previous $3.76 Million 3.65%
% of portfolio
0.08%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$27.7 - $31.39 $8,614 - $9,762
311 Added 0.23%
134,515 $3.89 Million
Q2 2024

Aug 01, 2024
SELL
$25.26 - $29.6 $257,500 - $301,742
-10,194 Reduced 7.06%
134,204 $3.76 Million
Q1 2024

May 08, 2024
SELL
$25.89 - $29.73 $102,860 - $118,117
-3,973 Reduced 2.68%
144,398 $4.01 Million
Q4 2023

Jan 29, 2024
SELL
$26.13 - $33.94 $122,784 - $159,484
-4,699 Reduced 3.07%
148,371 $4.27 Million
Q3 2023

Nov 15, 2023
BUY
$32.09 - $37.51 $3.94 Million - $4.6 Million
122,636 Added 402.96%
153,070 $5.08 Million
Q2 2023

Aug 15, 2023
BUY
$36.12 - $41.79 $37,456 - $43,336
1,037 Added 3.53%
30,434 $1.12 Million
Q1 2023

May 12, 2023
SELL
$39.39 - $51.28 $57,627 - $75,022
-1,463 Reduced 4.74%
29,397 $1.2 Million
Q4 2022

Feb 14, 2023
SELL
$41.75 - $54.5 $47,511 - $62,021
-1,138 Reduced 3.56%
30,860 $1.58 Million
Q3 2022

Oct 26, 2022
BUY
$43.76 - $53.42 $9,977 - $12,179
228 Added 0.72%
31,998 $1.4 Million
Q2 2022

Jul 07, 2022
SELL
$46.53 - $55.17 $89,477 - $106,091
-1,923 Reduced 5.71%
31,770 $1.67 Million
Q1 2022

Apr 12, 2022
BUY
$45.75 - $56.69 $63,318 - $78,458
1,384 Added 4.28%
33,693 $1.74 Million
Q4 2021

Feb 15, 2022
BUY
$41.32 - $61.25 $5,041 - $7,472
122 Added 0.38%
32,309 $1.91 Million
Q3 2021

Nov 03, 2021
BUY
$39.25 - $50.42 $60,209 - $77,344
1,534 Added 5.0%
32,187 $1.38 Million
Q2 2021

Aug 13, 2021
SELL
$35.91 - $40.68 $141,234 - $159,994
-3,933 Reduced 11.37%
30,653 $1.2 Million
Q1 2021

Apr 21, 2021
BUY
$33.49 - $37.77 $70,329 - $79,317
2,100 Added 6.46%
34,586 $1.25 Million
Q4 2020

Feb 09, 2021
BUY
$33.47 - $42.56 $176,018 - $223,823
5,259 Added 19.32%
32,486 $1.2 Million
Q3 2020

Oct 06, 2020
SELL
$31.75 - $37.25 $15,906 - $18,662
-501 Reduced 1.81%
27,227 $999,000
Q2 2020

Aug 14, 2020
SELL
$30.12 - $36.54 $49,005 - $59,450
-1,627 Reduced 5.54%
27,728 $860,000
Q1 2020

May 15, 2020
SELL
$27.03 - $38.62 $72,089 - $102,999
-2,667 Reduced 8.33%
29,355 $958,000
Q4 2019

Feb 12, 2020
SELL
$32.92 - $37.36 $823 - $934
-25 Reduced 0.08%
32,022 $1.26 Million
Q3 2019

Nov 13, 2019
BUY
$32.49 - $42.13 $52,081 - $67,534
1,603 Added 5.27%
32,047 $1.15 Million
Q2 2019

Aug 14, 2019
BUY
$36.98 - $41.52 $259,599 - $291,470
7,020 Added 29.97%
30,444 $1.32 Million
Q1 2019

May 09, 2019
SELL
$37.5 - $41.2 $30,562 - $33,578
-815 Reduced 3.36%
23,424 $995,000
Q4 2018

Feb 14, 2019
BUY
$38.47 - $43.86 $186,310 - $212,413
4,843 Added 24.97%
24,239 $1.06 Million
Q3 2018

Nov 15, 2018
BUY
$34.47 - $41.81 $27,265 - $33,071
791 Added 4.25%
19,396 $855,000
Q2 2018

Aug 14, 2018
SELL
$32.98 - $35.16 $22,129 - $23,592
-671 Reduced 3.48%
18,605 $0
Q1 2018

May 14, 2018
SELL
$31.91 - $37.02 $76,871 - $89,181
-2,409 Reduced 11.11%
19,276 $684,000
Q4 2017

Jan 11, 2018
BUY
$33.26 - $35.29 $61,131 - $64,863
1,838 Added 9.26%
21,685 $785,000
Q3 2017

Nov 20, 2017
BUY
$31.0 - $34.15 $615,257 - $677,775
19,847
19,847 $709,000

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email